GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Scaled Net Operating Assets

A Plus Biotechnology Co (ROCO:6918) Scaled Net Operating Assets : 0.55 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is A Plus Biotechnology Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

A Plus Biotechnology Co's operating assets for the quarter that ended in Dec. 2024 was NT$785.3 Mil. A Plus Biotechnology Co's operating liabilities for the quarter that ended in Dec. 2024 was NT$151.5 Mil. A Plus Biotechnology Co's Total Assets for the quarter that ended in Sep. 2024 was NT$1,153.9 Mil. Therefore, A Plus Biotechnology Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.55.


A Plus Biotechnology Co Scaled Net Operating Assets Historical Data

The historical data trend for A Plus Biotechnology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

A Plus Biotechnology Co Scaled Net Operating Assets Chart

A Plus Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.56 0.81 0.65 0.53 0.59

A Plus Biotechnology Co Quarterly Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.55 0.58 0.55

Competitive Comparison of A Plus Biotechnology Co's Scaled Net Operating Assets

For the Medical Devices subindustry, A Plus Biotechnology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


A Plus Biotechnology Co's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, A Plus Biotechnology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where A Plus Biotechnology Co's Scaled Net Operating Assets falls into.


;
;

A Plus Biotechnology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

A Plus Biotechnology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(785.346-151.457)/1071.323
=0.59

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1177.314 - 391.968
=785.346

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=258.269 - 94.016 - 12.796
=151.457

A Plus Biotechnology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(785.346-151.457)/1153.941
=0.55

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1177.314 - 391.968
=785.346

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=258.269 - 94.016 - 12.796
=151.457

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


A Plus Biotechnology Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of A Plus Biotechnology Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


A Plus Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN
A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.

A Plus Biotechnology Co Headlines

No Headlines